Skip to content
Recall Observatory FDA recall evidence

Device evidence

device-recall:cfres:198460

Atellica CH Triglycerides_2: in vitro diagnostic use in the quantitative determination of triglycerides in human serum and plasma (lithium heparin, sodium heparin, potassium EDTA) using the Atellica CH Analyzer. SMN: 11537222

Official recall number

Z-1271-2023

Evidence summary

Product code
CDT
Recall status
Open, Classified
Event initiated
January 27, 2023
Root cause
Under Investigation by firm
Source snapshot
5482458777762b1480c71ac49b2913b9c7984bb55aac66a4315d018da7cfed2c
Product
Z-1271-2023

Field note

Send feedback

We'll only use this to respond to your feedback.